Login
Search
Search
0 Dates
2025
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
CPC 2025
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Baseline Cardiovascular Risk and Primary Prevention in STEMI Patients: Insights from a Tertiary Center
Session:
SESSÃO DE POSTERS 46 - EPIDEMIOLOGIA PORTUGUESA NO FOCO
Speaker:
Carla Rafaela de Oliveira Ferreira
Congress:
CPC 2025
Topic:
J. Preventive Cardiology
Theme:
28. Risk Factors and Prevention
Subtheme:
28.2 Risk Factors and Prevention – Cardiovascular Risk Assessment
Session Type:
Cartazes
FP Number:
---
Authors:
Carla Oliveira Ferreira; Filipe Silva Vilela; Ana Sofia Fernandes; Mónica Dias; Inês Conde; Rodrigo Silva; Carlos Galvão Braga; Cátia Costa Oliveira
Abstract
<p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Aptos,sans-serif"><strong>Introduction: </strong>Systematic or opportunistic cardiovascular disease (CVD) risk assessment is of paramount importance in identifying individuals at high and very high risk for CVD, especially those who could benefit from pharmacological intervention in primary prevention. The aim of this study is to evaluate baseline CVD risk of patients admitted with ST-elevation myocardial infarction (STEMI) at a tertiary hospital, assess STEP 1 and STEP 2 accomplishment and determine predictors of appropriate CVD control.<strong> </strong></span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Aptos,sans-serif"><strong>Methods: </strong>We conducted a retrospective, observational study of 202 patients diagnosed with STEMI between January 1st, 2022 and March 31, 2023, with a median follow up of 27.3 (7) months. Risk stratification was performed using the ESC 2021 Guidelines on cardiovascular disease prevention in clinical practice, and compliance with STEP 1 and STEP 2 (target LDL-C and systolic blood pressure control) was analysed. Lifestyle changes were not addressed in this study.</span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Aptos,sans-serif"><strong>Results: </strong>The study cohort comprised 202 patients, with a mean age of 61.8 years (±11.4) and 85.1% male patients. CV risk stratification identified 3.5% (n= 7) of patients with low to moderate risk, 56.4% (n= 114) with high risk, and 40.1% (n= 81) with very high risk. Concerning CV risk control at the time of the event, only 10.9% of patients (n=22) met STEP 1 criteria, and just 2 (9.5%) achieved STEP 2 targets. Statin use was higher in patients meeting STEP 1 criteria (45.5%) compared to those who did not (31.7%). Age was significantly associated with the accomplishment of STEP 1 in both univariate (OR: 1.06; p= 0.009) and multivariate (OR: 1.069; p= 0.001) analysis. Statin use, prior to CV risk classification and recent analytical study at the general practitioner showed no significant association with STEP 1 compliance.</span></span></p> <p><strong><span style="font-size:11.0pt"><span style="font-family:"Aptos",sans-serif">Conclusion: </span></span></strong><span style="font-size:11.0pt"><span style="font-family:"Aptos",sans-serif">This study highlights an alarming gap in the primary prevention of patients who develop STEMI, with the majority failing to meet STEP 1 and STEP 2 recommendations despite their high baseline CVD risk. Age emerged as a positive predictor of compliance with CV prevention strategies, emphasizing the need for targeted interventions to improve adherence to guideline recommendations, particularly among the younger population.</span></span><br /> </p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site